nodes	percent_of_prediction	percent_of_DWPC	metapath
Brimonidine—AOX1—Methotrexate—stomach cancer	0.377	1	CbGbCtD
Brimonidine—Nasopharyngitis—Epirubicin—stomach cancer	0.000627	0.00138	CcSEcCtD
Brimonidine—Face oedema—Doxorubicin—stomach cancer	0.000626	0.00138	CcSEcCtD
Brimonidine—Erythema—Docetaxel—stomach cancer	0.000626	0.00138	CcSEcCtD
Brimonidine—Dyspepsia—Fluorouracil—stomach cancer	0.000623	0.00138	CcSEcCtD
Brimonidine—Arrhythmia—Capecitabine—stomach cancer	0.000622	0.00137	CcSEcCtD
Brimonidine—Dysgeusia—Docetaxel—stomach cancer	0.000613	0.00135	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Fluorouracil—stomach cancer	0.000611	0.00135	CcSEcCtD
Brimonidine—Mental disorder—Capecitabine—stomach cancer	0.00061	0.00135	CcSEcCtD
Brimonidine—Erythema—Capecitabine—stomach cancer	0.000606	0.00134	CcSEcCtD
Brimonidine—Influenza—Epirubicin—stomach cancer	0.000606	0.00134	CcSEcCtD
Brimonidine—Pain—Fluorouracil—stomach cancer	0.000605	0.00134	CcSEcCtD
Brimonidine—Dry skin—Doxorubicin—stomach cancer	0.000594	0.00131	CcSEcCtD
Brimonidine—Dysgeusia—Capecitabine—stomach cancer	0.000593	0.00131	CcSEcCtD
Brimonidine—Bronchitis—Epirubicin—stomach cancer	0.000583	0.00129	CcSEcCtD
Brimonidine—Nasopharyngitis—Doxorubicin—stomach cancer	0.00058	0.00128	CcSEcCtD
Brimonidine—Drowsiness—Methotrexate—stomach cancer	0.000577	0.00127	CcSEcCtD
Brimonidine—Depression—Methotrexate—stomach cancer	0.000576	0.00127	CcSEcCtD
Brimonidine—Vision blurred—Capecitabine—stomach cancer	0.000571	0.00126	CcSEcCtD
Brimonidine—Syncope—Docetaxel—stomach cancer	0.000561	0.00124	CcSEcCtD
Brimonidine—Conjunctivitis—Methotrexate—stomach cancer	0.000561	0.00124	CcSEcCtD
Brimonidine—Influenza—Doxorubicin—stomach cancer	0.000561	0.00124	CcSEcCtD
Brimonidine—Palpitations—Docetaxel—stomach cancer	0.000553	0.00122	CcSEcCtD
Brimonidine—Loss of consciousness—Docetaxel—stomach cancer	0.00055	0.00121	CcSEcCtD
Brimonidine—Cough—Docetaxel—stomach cancer	0.000546	0.00121	CcSEcCtD
Brimonidine—Hypersensitivity—Irinotecan—stomach cancer	0.000544	0.0012	CcSEcCtD
Brimonidine—Syncope—Capecitabine—stomach cancer	0.000543	0.0012	CcSEcCtD
Brimonidine—Hypertension—Docetaxel—stomach cancer	0.00054	0.00119	CcSEcCtD
Brimonidine—Drowsiness—Epirubicin—stomach cancer	0.00054	0.00119	CcSEcCtD
Brimonidine—Bronchitis—Doxorubicin—stomach cancer	0.000539	0.00119	CcSEcCtD
Brimonidine—Palpitations—Capecitabine—stomach cancer	0.000535	0.00118	CcSEcCtD
Brimonidine—Myalgia—Docetaxel—stomach cancer	0.000533	0.00118	CcSEcCtD
Brimonidine—Chest pain—Docetaxel—stomach cancer	0.000533	0.00118	CcSEcCtD
Brimonidine—Arthralgia—Docetaxel—stomach cancer	0.000533	0.00118	CcSEcCtD
Brimonidine—Loss of consciousness—Capecitabine—stomach cancer	0.000533	0.00118	CcSEcCtD
Brimonidine—Asthenia—Irinotecan—stomach cancer	0.00053	0.00117	CcSEcCtD
Brimonidine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—stomach cancer	0.000529	0.00117	CcSEcCtD
Brimonidine—Cough—Capecitabine—stomach cancer	0.000529	0.00117	CcSEcCtD
Brimonidine—Conjunctivitis—Epirubicin—stomach cancer	0.000525	0.00116	CcSEcCtD
Brimonidine—Hypertension—Capecitabine—stomach cancer	0.000523	0.00116	CcSEcCtD
Brimonidine—Hypersensitivity—Fluorouracil—stomach cancer	0.000521	0.00115	CcSEcCtD
Brimonidine—Dry mouth—Docetaxel—stomach cancer	0.000521	0.00115	CcSEcCtD
Brimonidine—Chest pain—Capecitabine—stomach cancer	0.000516	0.00114	CcSEcCtD
Brimonidine—Myalgia—Capecitabine—stomach cancer	0.000516	0.00114	CcSEcCtD
Brimonidine—Arthralgia—Capecitabine—stomach cancer	0.000516	0.00114	CcSEcCtD
Brimonidine—Pharyngitis—Methotrexate—stomach cancer	0.000514	0.00114	CcSEcCtD
Brimonidine—Anxiety—Capecitabine—stomach cancer	0.000514	0.00114	CcSEcCtD
Brimonidine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.000512	0.00113	CcSEcCtD
Brimonidine—Oedema—Docetaxel—stomach cancer	0.000511	0.00113	CcSEcCtD
Brimonidine—Discomfort—Capecitabine—stomach cancer	0.00051	0.00113	CcSEcCtD
Brimonidine—Infection—Docetaxel—stomach cancer	0.000507	0.00112	CcSEcCtD
Brimonidine—Sinusitis—Epirubicin—stomach cancer	0.000507	0.00112	CcSEcCtD
Brimonidine—Dry mouth—Capecitabine—stomach cancer	0.000504	0.00111	CcSEcCtD
Brimonidine—Shock—Docetaxel—stomach cancer	0.000502	0.00111	CcSEcCtD
Brimonidine—Nervous system disorder—Docetaxel—stomach cancer	0.000501	0.00111	CcSEcCtD
Brimonidine—Pruritus—Fluorouracil—stomach cancer	0.000501	0.00111	CcSEcCtD
Brimonidine—Drowsiness—Doxorubicin—stomach cancer	0.0005	0.0011	CcSEcCtD
Brimonidine—Visual impairment—Methotrexate—stomach cancer	0.000499	0.0011	CcSEcCtD
Brimonidine—Tachycardia—Docetaxel—stomach cancer	0.000498	0.0011	CcSEcCtD
Brimonidine—Skin disorder—Docetaxel—stomach cancer	0.000496	0.0011	CcSEcCtD
Brimonidine—Oedema—Capecitabine—stomach cancer	0.000494	0.00109	CcSEcCtD
Brimonidine—Bradycardia—Epirubicin—stomach cancer	0.000494	0.00109	CcSEcCtD
Brimonidine—Infection—Capecitabine—stomach cancer	0.000491	0.00109	CcSEcCtD
Brimonidine—Dizziness—Irinotecan—stomach cancer	0.000489	0.00108	CcSEcCtD
Brimonidine—Shock—Capecitabine—stomach cancer	0.000486	0.00107	CcSEcCtD
Brimonidine—Rhinitis—Epirubicin—stomach cancer	0.000486	0.00107	CcSEcCtD
Brimonidine—Conjunctivitis—Doxorubicin—stomach cancer	0.000486	0.00107	CcSEcCtD
Brimonidine—Nervous system disorder—Capecitabine—stomach cancer	0.000485	0.00107	CcSEcCtD
Brimonidine—Eye disorder—Methotrexate—stomach cancer	0.000484	0.00107	CcSEcCtD
Brimonidine—Tachycardia—Capecitabine—stomach cancer	0.000483	0.00107	CcSEcCtD
Brimonidine—Pharyngitis—Epirubicin—stomach cancer	0.000481	0.00106	CcSEcCtD
Brimonidine—Cardiac disorder—Methotrexate—stomach cancer	0.000481	0.00106	CcSEcCtD
Brimonidine—Skin disorder—Capecitabine—stomach cancer	0.00048	0.00106	CcSEcCtD
Brimonidine—Hypotension—Docetaxel—stomach cancer	0.000477	0.00105	CcSEcCtD
Brimonidine—Angiopathy—Methotrexate—stomach cancer	0.00047	0.00104	CcSEcCtD
Brimonidine—Sinusitis—Doxorubicin—stomach cancer	0.000469	0.00104	CcSEcCtD
Brimonidine—Immune system disorder—Methotrexate—stomach cancer	0.000468	0.00103	CcSEcCtD
Brimonidine—Dizziness—Fluorouracil—stomach cancer	0.000468	0.00103	CcSEcCtD
Brimonidine—Visual impairment—Epirubicin—stomach cancer	0.000467	0.00103	CcSEcCtD
Brimonidine—Mediastinal disorder—Methotrexate—stomach cancer	0.000467	0.00103	CcSEcCtD
Brimonidine—Rash—Irinotecan—stomach cancer	0.000466	0.00103	CcSEcCtD
Brimonidine—Dermatitis—Irinotecan—stomach cancer	0.000465	0.00103	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000465	0.00103	CcSEcCtD
Brimonidine—Headache—Irinotecan—stomach cancer	0.000463	0.00102	CcSEcCtD
Brimonidine—Hypotension—Capecitabine—stomach cancer	0.000462	0.00102	CcSEcCtD
Brimonidine—Insomnia—Docetaxel—stomach cancer	0.000462	0.00102	CcSEcCtD
Brimonidine—Paraesthesia—Docetaxel—stomach cancer	0.000459	0.00101	CcSEcCtD
Brimonidine—Bradycardia—Doxorubicin—stomach cancer	0.000457	0.00101	CcSEcCtD
Brimonidine—Dyspnoea—Docetaxel—stomach cancer	0.000455	0.00101	CcSEcCtD
Brimonidine—Somnolence—Docetaxel—stomach cancer	0.000454	0.001	CcSEcCtD
Brimonidine—Mental disorder—Methotrexate—stomach cancer	0.000454	0.001	CcSEcCtD
Brimonidine—Eye disorder—Epirubicin—stomach cancer	0.000453	0.001	CcSEcCtD
Brimonidine—Erythema—Methotrexate—stomach cancer	0.000451	0.000996	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000451	0.000995	CcSEcCtD
Brimonidine—Cardiac disorder—Epirubicin—stomach cancer	0.00045	0.000994	CcSEcCtD
Brimonidine—Flushing—Epirubicin—stomach cancer	0.00045	0.000994	CcSEcCtD
Brimonidine—Rhinitis—Doxorubicin—stomach cancer	0.00045	0.000994	CcSEcCtD
Brimonidine—Dyspepsia—Docetaxel—stomach cancer	0.00045	0.000993	CcSEcCtD
Brimonidine—Insomnia—Capecitabine—stomach cancer	0.000447	0.000988	CcSEcCtD
Brimonidine—Rash—Fluorouracil—stomach cancer	0.000446	0.000986	CcSEcCtD
Brimonidine—Dermatitis—Fluorouracil—stomach cancer	0.000446	0.000985	CcSEcCtD
Brimonidine—Pharyngitis—Doxorubicin—stomach cancer	0.000445	0.000984	CcSEcCtD
Brimonidine—Paraesthesia—Capecitabine—stomach cancer	0.000444	0.000981	CcSEcCtD
Brimonidine—Headache—Fluorouracil—stomach cancer	0.000443	0.000979	CcSEcCtD
Brimonidine—Dysgeusia—Methotrexate—stomach cancer	0.000442	0.000976	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000441	0.000974	CcSEcCtD
Brimonidine—Dyspnoea—Capecitabine—stomach cancer	0.000441	0.000974	CcSEcCtD
Brimonidine—Fatigue—Docetaxel—stomach cancer	0.00044	0.000973	CcSEcCtD
Brimonidine—Angiopathy—Epirubicin—stomach cancer	0.00044	0.000972	CcSEcCtD
Brimonidine—Nausea—Irinotecan—stomach cancer	0.000439	0.000969	CcSEcCtD
Brimonidine—Immune system disorder—Epirubicin—stomach cancer	0.000438	0.000967	CcSEcCtD
Brimonidine—Mediastinal disorder—Epirubicin—stomach cancer	0.000437	0.000965	CcSEcCtD
Brimonidine—Pain—Docetaxel—stomach cancer	0.000437	0.000965	CcSEcCtD
Brimonidine—Dyspepsia—Capecitabine—stomach cancer	0.000435	0.000962	CcSEcCtD
Brimonidine—Arrhythmia—Epirubicin—stomach cancer	0.000433	0.000957	CcSEcCtD
Brimonidine—Visual impairment—Doxorubicin—stomach cancer	0.000432	0.000955	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000427	0.000943	CcSEcCtD
Brimonidine—Fatigue—Capecitabine—stomach cancer	0.000426	0.000942	CcSEcCtD
Brimonidine—Vision blurred—Methotrexate—stomach cancer	0.000425	0.000939	CcSEcCtD
Brimonidine—Mental disorder—Epirubicin—stomach cancer	0.000425	0.000938	CcSEcCtD
Brimonidine—Pain—Capecitabine—stomach cancer	0.000423	0.000934	CcSEcCtD
Brimonidine—Erythema—Epirubicin—stomach cancer	0.000422	0.000932	CcSEcCtD
Brimonidine—Nausea—Fluorouracil—stomach cancer	0.00042	0.000928	CcSEcCtD
Brimonidine—Eye disorder—Doxorubicin—stomach cancer	0.000419	0.000926	CcSEcCtD
Brimonidine—Cardiac disorder—Doxorubicin—stomach cancer	0.000416	0.00092	CcSEcCtD
Brimonidine—Flushing—Doxorubicin—stomach cancer	0.000416	0.00092	CcSEcCtD
Brimonidine—Dysgeusia—Epirubicin—stomach cancer	0.000413	0.000913	CcSEcCtD
Brimonidine—Angiopathy—Doxorubicin—stomach cancer	0.000407	0.000899	CcSEcCtD
Brimonidine—Immune system disorder—Doxorubicin—stomach cancer	0.000405	0.000895	CcSEcCtD
Brimonidine—Mediastinal disorder—Doxorubicin—stomach cancer	0.000404	0.000893	CcSEcCtD
Brimonidine—Arrhythmia—Doxorubicin—stomach cancer	0.000401	0.000885	CcSEcCtD
Brimonidine—Vision blurred—Epirubicin—stomach cancer	0.000398	0.000879	CcSEcCtD
Brimonidine—Cough—Methotrexate—stomach cancer	0.000394	0.000869	CcSEcCtD
Brimonidine—Mental disorder—Doxorubicin—stomach cancer	0.000393	0.000868	CcSEcCtD
Brimonidine—Erythema—Doxorubicin—stomach cancer	0.000391	0.000863	CcSEcCtD
Brimonidine—Chest pain—Methotrexate—stomach cancer	0.000384	0.000848	CcSEcCtD
Brimonidine—Arthralgia—Methotrexate—stomach cancer	0.000384	0.000848	CcSEcCtD
Brimonidine—Myalgia—Methotrexate—stomach cancer	0.000384	0.000848	CcSEcCtD
Brimonidine—Dysgeusia—Doxorubicin—stomach cancer	0.000382	0.000845	CcSEcCtD
Brimonidine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000381	0.000842	CcSEcCtD
Brimonidine—Discomfort—Methotrexate—stomach cancer	0.000379	0.000838	CcSEcCtD
Brimonidine—Syncope—Epirubicin—stomach cancer	0.000379	0.000836	CcSEcCtD
Brimonidine—Hypersensitivity—Docetaxel—stomach cancer	0.000376	0.000831	CcSEcCtD
Brimonidine—Palpitations—Epirubicin—stomach cancer	0.000373	0.000824	CcSEcCtD
Brimonidine—Loss of consciousness—Epirubicin—stomach cancer	0.000371	0.00082	CcSEcCtD
Brimonidine—Cough—Epirubicin—stomach cancer	0.000368	0.000814	CcSEcCtD
Brimonidine—Vision blurred—Doxorubicin—stomach cancer	0.000368	0.000813	CcSEcCtD
Brimonidine—Asthenia—Docetaxel—stomach cancer	0.000366	0.000809	CcSEcCtD
Brimonidine—Infection—Methotrexate—stomach cancer	0.000366	0.000808	CcSEcCtD
Brimonidine—Hypertension—Epirubicin—stomach cancer	0.000364	0.000805	CcSEcCtD
Brimonidine—Hypersensitivity—Capecitabine—stomach cancer	0.000364	0.000805	CcSEcCtD
Brimonidine—Pruritus—Docetaxel—stomach cancer	0.000361	0.000798	CcSEcCtD
Brimonidine—Nervous system disorder—Methotrexate—stomach cancer	0.000361	0.000797	CcSEcCtD
Brimonidine—Arthralgia—Epirubicin—stomach cancer	0.000359	0.000794	CcSEcCtD
Brimonidine—Myalgia—Epirubicin—stomach cancer	0.000359	0.000794	CcSEcCtD
Brimonidine—Chest pain—Epirubicin—stomach cancer	0.000359	0.000794	CcSEcCtD
Brimonidine—Anxiety—Epirubicin—stomach cancer	0.000358	0.000791	CcSEcCtD
Brimonidine—Skin disorder—Methotrexate—stomach cancer	0.000358	0.00079	CcSEcCtD
Brimonidine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000357	0.000788	CcSEcCtD
Brimonidine—Discomfort—Epirubicin—stomach cancer	0.000355	0.000784	CcSEcCtD
Brimonidine—Asthenia—Capecitabine—stomach cancer	0.000355	0.000784	CcSEcCtD
Brimonidine—Dry mouth—Epirubicin—stomach cancer	0.000351	0.000776	CcSEcCtD
Brimonidine—Syncope—Doxorubicin—stomach cancer	0.00035	0.000774	CcSEcCtD
Brimonidine—Pruritus—Capecitabine—stomach cancer	0.00035	0.000773	CcSEcCtD
Brimonidine—Palpitations—Doxorubicin—stomach cancer	0.000345	0.000762	CcSEcCtD
Brimonidine—Oedema—Epirubicin—stomach cancer	0.000344	0.000761	CcSEcCtD
Brimonidine—Hypotension—Methotrexate—stomach cancer	0.000344	0.00076	CcSEcCtD
Brimonidine—Loss of consciousness—Doxorubicin—stomach cancer	0.000343	0.000758	CcSEcCtD
Brimonidine—Infection—Epirubicin—stomach cancer	0.000342	0.000756	CcSEcCtD
Brimonidine—Cough—Doxorubicin—stomach cancer	0.000341	0.000753	CcSEcCtD
Brimonidine—Shock—Epirubicin—stomach cancer	0.000339	0.000749	CcSEcCtD
Brimonidine—Nervous system disorder—Epirubicin—stomach cancer	0.000338	0.000746	CcSEcCtD
Brimonidine—Dizziness—Docetaxel—stomach cancer	0.000338	0.000746	CcSEcCtD
Brimonidine—Hypertension—Doxorubicin—stomach cancer	0.000337	0.000745	CcSEcCtD
Brimonidine—Tachycardia—Epirubicin—stomach cancer	0.000336	0.000743	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000335	0.000741	CcSEcCtD
Brimonidine—Skin disorder—Epirubicin—stomach cancer	0.000335	0.000739	CcSEcCtD
Brimonidine—Insomnia—Methotrexate—stomach cancer	0.000333	0.000735	CcSEcCtD
Brimonidine—Myalgia—Doxorubicin—stomach cancer	0.000332	0.000734	CcSEcCtD
Brimonidine—Chest pain—Doxorubicin—stomach cancer	0.000332	0.000734	CcSEcCtD
Brimonidine—Arthralgia—Doxorubicin—stomach cancer	0.000332	0.000734	CcSEcCtD
Brimonidine—Anxiety—Doxorubicin—stomach cancer	0.000331	0.000732	CcSEcCtD
Brimonidine—Paraesthesia—Methotrexate—stomach cancer	0.000331	0.00073	CcSEcCtD
Brimonidine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.00033	0.000729	CcSEcCtD
Brimonidine—Discomfort—Doxorubicin—stomach cancer	0.000329	0.000726	CcSEcCtD
Brimonidine—Dyspnoea—Methotrexate—stomach cancer	0.000328	0.000725	CcSEcCtD
Brimonidine—Somnolence—Methotrexate—stomach cancer	0.000327	0.000723	CcSEcCtD
Brimonidine—Dizziness—Capecitabine—stomach cancer	0.000327	0.000722	CcSEcCtD
Brimonidine—Dry mouth—Doxorubicin—stomach cancer	0.000325	0.000718	CcSEcCtD
Brimonidine—Dyspepsia—Methotrexate—stomach cancer	0.000324	0.000716	CcSEcCtD
Brimonidine—Rash—Docetaxel—stomach cancer	0.000322	0.000711	CcSEcCtD
Brimonidine—Hypotension—Epirubicin—stomach cancer	0.000322	0.000711	CcSEcCtD
Brimonidine—Dermatitis—Docetaxel—stomach cancer	0.000322	0.000711	CcSEcCtD
Brimonidine—Headache—Docetaxel—stomach cancer	0.00032	0.000707	CcSEcCtD
Brimonidine—Oedema—Doxorubicin—stomach cancer	0.000319	0.000704	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000318	0.000702	CcSEcCtD
Brimonidine—Fatigue—Methotrexate—stomach cancer	0.000317	0.000701	CcSEcCtD
Brimonidine—Infection—Doxorubicin—stomach cancer	0.000317	0.0007	CcSEcCtD
Brimonidine—Pain—Methotrexate—stomach cancer	0.000315	0.000695	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000314	0.000693	CcSEcCtD
Brimonidine—Shock—Doxorubicin—stomach cancer	0.000314	0.000693	CcSEcCtD
Brimonidine—Nervous system disorder—Doxorubicin—stomach cancer	0.000313	0.000691	CcSEcCtD
Brimonidine—Rash—Capecitabine—stomach cancer	0.000312	0.000689	CcSEcCtD
Brimonidine—Insomnia—Epirubicin—stomach cancer	0.000312	0.000688	CcSEcCtD
Brimonidine—Dermatitis—Capecitabine—stomach cancer	0.000311	0.000688	CcSEcCtD
Brimonidine—Tachycardia—Doxorubicin—stomach cancer	0.000311	0.000687	CcSEcCtD
Brimonidine—Headache—Capecitabine—stomach cancer	0.00031	0.000684	CcSEcCtD
Brimonidine—Skin disorder—Doxorubicin—stomach cancer	0.00031	0.000684	CcSEcCtD
Brimonidine—Paraesthesia—Epirubicin—stomach cancer	0.000309	0.000683	CcSEcCtD
Brimonidine—Dyspnoea—Epirubicin—stomach cancer	0.000307	0.000678	CcSEcCtD
Brimonidine—Somnolence—Epirubicin—stomach cancer	0.000306	0.000677	CcSEcCtD
Brimonidine—Nausea—Docetaxel—stomach cancer	0.000303	0.00067	CcSEcCtD
Brimonidine—Dyspepsia—Epirubicin—stomach cancer	0.000303	0.00067	CcSEcCtD
Brimonidine—Hypotension—Doxorubicin—stomach cancer	0.000298	0.000658	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000297	0.000657	CcSEcCtD
Brimonidine—Fatigue—Epirubicin—stomach cancer	0.000297	0.000656	CcSEcCtD
Brimonidine—Pain—Epirubicin—stomach cancer	0.000295	0.000651	CcSEcCtD
Brimonidine—Nausea—Capecitabine—stomach cancer	0.000294	0.000649	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.00029	0.000641	CcSEcCtD
Brimonidine—Insomnia—Doxorubicin—stomach cancer	0.000288	0.000637	CcSEcCtD
Brimonidine—Paraesthesia—Doxorubicin—stomach cancer	0.000286	0.000632	CcSEcCtD
Brimonidine—Dyspnoea—Doxorubicin—stomach cancer	0.000284	0.000628	CcSEcCtD
Brimonidine—Somnolence—Doxorubicin—stomach cancer	0.000283	0.000626	CcSEcCtD
Brimonidine—Dyspepsia—Doxorubicin—stomach cancer	0.000281	0.00062	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000275	0.000608	CcSEcCtD
Brimonidine—Fatigue—Doxorubicin—stomach cancer	0.000275	0.000607	CcSEcCtD
Brimonidine—Pain—Doxorubicin—stomach cancer	0.000273	0.000602	CcSEcCtD
Brimonidine—Hypersensitivity—Methotrexate—stomach cancer	0.000271	0.000599	CcSEcCtD
Brimonidine—Asthenia—Methotrexate—stomach cancer	0.000264	0.000583	CcSEcCtD
Brimonidine—Pruritus—Methotrexate—stomach cancer	0.00026	0.000575	CcSEcCtD
Brimonidine—Hypersensitivity—Epirubicin—stomach cancer	0.000254	0.000561	CcSEcCtD
Brimonidine—Asthenia—Epirubicin—stomach cancer	0.000247	0.000546	CcSEcCtD
Brimonidine—Pruritus—Epirubicin—stomach cancer	0.000244	0.000538	CcSEcCtD
Brimonidine—Dizziness—Methotrexate—stomach cancer	0.000243	0.000538	CcSEcCtD
Brimonidine—Hypersensitivity—Doxorubicin—stomach cancer	0.000235	0.000519	CcSEcCtD
Brimonidine—Rash—Methotrexate—stomach cancer	0.000232	0.000513	CcSEcCtD
Brimonidine—Dermatitis—Methotrexate—stomach cancer	0.000232	0.000512	CcSEcCtD
Brimonidine—Headache—Methotrexate—stomach cancer	0.000231	0.000509	CcSEcCtD
Brimonidine—Asthenia—Doxorubicin—stomach cancer	0.000229	0.000505	CcSEcCtD
Brimonidine—Dizziness—Epirubicin—stomach cancer	0.000228	0.000503	CcSEcCtD
Brimonidine—Pruritus—Doxorubicin—stomach cancer	0.000226	0.000498	CcSEcCtD
Brimonidine—Nausea—Methotrexate—stomach cancer	0.000219	0.000483	CcSEcCtD
Brimonidine—Rash—Epirubicin—stomach cancer	0.000217	0.00048	CcSEcCtD
Brimonidine—Dermatitis—Epirubicin—stomach cancer	0.000217	0.000479	CcSEcCtD
Brimonidine—Headache—Epirubicin—stomach cancer	0.000216	0.000477	CcSEcCtD
Brimonidine—Dizziness—Doxorubicin—stomach cancer	0.000211	0.000466	CcSEcCtD
Brimonidine—Nausea—Epirubicin—stomach cancer	0.000205	0.000452	CcSEcCtD
Brimonidine—Rash—Doxorubicin—stomach cancer	0.000201	0.000444	CcSEcCtD
Brimonidine—Dermatitis—Doxorubicin—stomach cancer	0.000201	0.000444	CcSEcCtD
Brimonidine—Headache—Doxorubicin—stomach cancer	0.0002	0.000441	CcSEcCtD
Brimonidine—Nausea—Doxorubicin—stomach cancer	0.000189	0.000418	CcSEcCtD
Brimonidine—ADRA2A—Signaling Pathways—FGG—stomach cancer	6.07e-05	0.000356	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—CD44—stomach cancer	6.01e-05	0.000352	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—ADRB2—stomach cancer	5.99e-05	0.000351	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—AGTR2—stomach cancer	5.98e-05	0.00035	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—HSPB1—stomach cancer	5.98e-05	0.00035	CbGpPWpGaD
Brimonidine—ADRA2B—GPCR downstream signaling—PRKCB—stomach cancer	5.96e-05	0.000349	CbGpPWpGaD
Brimonidine—ADRA2A—Hemostasis—SERPINE1—stomach cancer	5.96e-05	0.000349	CbGpPWpGaD
Brimonidine—AOX1—Metabolism—PTGS2—stomach cancer	5.95e-05	0.000349	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—ANXA1—stomach cancer	5.95e-05	0.000348	CbGpPWpGaD
Brimonidine—ADRA2A—Hemostasis—ALB—stomach cancer	5.95e-05	0.000348	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—F2R—stomach cancer	5.91e-05	0.000346	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—BMP2—stomach cancer	5.91e-05	0.000346	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—PPP2R1A—stomach cancer	5.87e-05	0.000344	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—GSTT1—stomach cancer	5.87e-05	0.000344	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—PRKAA1—stomach cancer	5.84e-05	0.000342	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—AKR1C3—stomach cancer	5.81e-05	0.00034	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—CYP2A6—stomach cancer	5.81e-05	0.00034	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—ADRB1—stomach cancer	5.76e-05	0.000337	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—HTR1A—stomach cancer	5.75e-05	0.000337	CbGpPWpGaD
Brimonidine—ADRA2A—Hemostasis—RHOA—stomach cancer	5.75e-05	0.000337	CbGpPWpGaD
Brimonidine—ADRA2A—Hemostasis—NOS3—stomach cancer	5.69e-05	0.000333	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—AKR1C3—stomach cancer	5.65e-05	0.000331	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—RBP4—stomach cancer	5.65e-05	0.000331	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR ligand binding—CXCL8—stomach cancer	5.64e-05	0.00033	CbGpPWpGaD
Brimonidine—ADRA2C—GPCR downstream signaling—PRKCB—stomach cancer	5.57e-05	0.000326	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—ANXA1—stomach cancer	5.56e-05	0.000325	CbGpPWpGaD
Brimonidine—AOX1—Disease—STAT3—stomach cancer	5.54e-05	0.000325	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—RPS6—stomach cancer	5.5e-05	0.000322	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—ENO1—stomach cancer	5.5e-05	0.000322	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—PRKCB—stomach cancer	5.42e-05	0.000317	CbGpPWpGaD
Brimonidine—ADRA2B—Hemostasis—VEGFA—stomach cancer	5.4e-05	0.000316	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—IL6ST—stomach cancer	5.39e-05	0.000316	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—ADRB1—stomach cancer	5.38e-05	0.000315	CbGpPWpGaD
Brimonidine—AOX1—Disease—MAPK3—stomach cancer	5.3e-05	0.00031	CbGpPWpGaD
Brimonidine—AOX1—Disease—MYC—stomach cancer	5.15e-05	0.000302	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—RPS6—stomach cancer	5.14e-05	0.000301	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—PPP2R1A—stomach cancer	5.11e-05	0.000299	CbGpPWpGaD
Brimonidine—ADRA2B—Hemostasis—MAPK3—stomach cancer	5.11e-05	0.000299	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—PRKCB—stomach cancer	5.06e-05	0.000296	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—HBEGF—stomach cancer	5.06e-05	0.000296	CbGpPWpGaD
Brimonidine—ADRA2C—Hemostasis—VEGFA—stomach cancer	5.04e-05	0.000295	CbGpPWpGaD
Brimonidine—AOX1—Disease—MAPK1—stomach cancer	5.04e-05	0.000295	CbGpPWpGaD
Brimonidine—AOX1—Disease—EGFR—stomach cancer	5.04e-05	0.000295	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—IL6ST—stomach cancer	5.04e-05	0.000295	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—GSTP1—stomach cancer	5.01e-05	0.000294	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—HMOX1—stomach cancer	4.94e-05	0.000289	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—CD44—stomach cancer	4.88e-05	0.000286	CbGpPWpGaD
Brimonidine—ADRA2B—Hemostasis—MAPK1—stomach cancer	4.86e-05	0.000285	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—HSPB1—stomach cancer	4.85e-05	0.000284	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—AGTR2—stomach cancer	4.85e-05	0.000284	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—IL6R—stomach cancer	4.81e-05	0.000282	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—F2R—stomach cancer	4.8e-05	0.000281	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—BMP2—stomach cancer	4.8e-05	0.000281	CbGpPWpGaD
Brimonidine—ADRA2B—GPCR downstream signaling—RHOA—stomach cancer	4.79e-05	0.00028	CbGpPWpGaD
Brimonidine—ADRA2C—Hemostasis—MAPK3—stomach cancer	4.77e-05	0.000279	CbGpPWpGaD
Brimonidine—AOX1—Disease—KRAS—stomach cancer	4.76e-05	0.000279	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—HBEGF—stomach cancer	4.72e-05	0.000277	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—AKR1C3—stomach cancer	4.72e-05	0.000277	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—HTR1A—stomach cancer	4.67e-05	0.000274	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—ADRB2—stomach cancer	4.67e-05	0.000273	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—TYMS—stomach cancer	4.66e-05	0.000273	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—GSTM1—stomach cancer	4.61e-05	0.00027	CbGpPWpGaD
Brimonidine—ADRA2B—Hemostasis—KRAS—stomach cancer	4.59e-05	0.000269	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—PPP2R1A—stomach cancer	4.57e-05	0.000268	CbGpPWpGaD
Brimonidine—ADRA2C—Hemostasis—MAPK1—stomach cancer	4.54e-05	0.000266	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR downstream signaling—PRKCB—stomach cancer	4.52e-05	0.000265	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—ANXA1—stomach cancer	4.51e-05	0.000264	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—IL6R—stomach cancer	4.49e-05	0.000263	CbGpPWpGaD
Brimonidine—ADRA2C—GPCR downstream signaling—RHOA—stomach cancer	4.47e-05	0.000262	CbGpPWpGaD
Brimonidine—AOX1—Disease—PIK3CA—stomach cancer	4.37e-05	0.000256	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—ADRB1—stomach cancer	4.37e-05	0.000256	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—ADRB2—stomach cancer	4.36e-05	0.000255	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—RHOA—stomach cancer	4.35e-05	0.000255	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—ERCC2—stomach cancer	4.33e-05	0.000254	CbGpPWpGaD
Brimonidine—ADRA2C—Hemostasis—KRAS—stomach cancer	4.29e-05	0.000251	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—PPP2R1A—stomach cancer	4.27e-05	0.00025	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—SMAD4—stomach cancer	4.25e-05	0.000249	CbGpPWpGaD
Brimonidine—ADRA2B—Hemostasis—PIK3CA—stomach cancer	4.22e-05	0.000247	CbGpPWpGaD
Brimonidine—ADRA2B—GPCR downstream signaling—CXCL8—stomach cancer	4.2e-05	0.000246	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—RPS6—stomach cancer	4.18e-05	0.000245	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—PPP2R1A—stomach cancer	4.15e-05	0.000243	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—PRKCB—stomach cancer	4.11e-05	0.000241	CbGpPWpGaD
Brimonidine—ADRA2A—Hemostasis—VEGFA—stomach cancer	4.1e-05	0.00024	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—IL6ST—stomach cancer	4.09e-05	0.00024	CbGpPWpGaD
Brimonidine—ADRA2B—Hemostasis—TP53—stomach cancer	4.08e-05	0.000239	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—GSTP1—stomach cancer	4.07e-05	0.000238	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—MTHFR—stomach cancer	4.07e-05	0.000238	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—RHOA—stomach cancer	4.06e-05	0.000238	CbGpPWpGaD
Brimonidine—AOX1—Disease—HRAS—stomach cancer	4.05e-05	0.000237	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—FYN—stomach cancer	4.03e-05	0.000236	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—HMOX1—stomach cancer	4.01e-05	0.000235	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—SMAD4—stomach cancer	3.97e-05	0.000232	CbGpPWpGaD
Brimonidine—ADRA2C—Hemostasis—PIK3CA—stomach cancer	3.94e-05	0.000231	CbGpPWpGaD
Brimonidine—ADRA2C—GPCR downstream signaling—CXCL8—stomach cancer	3.93e-05	0.00023	CbGpPWpGaD
Brimonidine—ADRA2B—Hemostasis—HRAS—stomach cancer	3.9e-05	0.000229	CbGpPWpGaD
Brimonidine—ADRA2A—Hemostasis—MAPK3—stomach cancer	3.88e-05	0.000227	CbGpPWpGaD
Brimonidine—AOX1—Disease—IL6—stomach cancer	3.87e-05	0.000227	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—HBEGF—stomach cancer	3.84e-05	0.000225	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—CXCL8—stomach cancer	3.82e-05	0.000223	CbGpPWpGaD
Brimonidine—ADRA2C—Hemostasis—TP53—stomach cancer	3.81e-05	0.000223	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—FGFR2—stomach cancer	3.79e-05	0.000222	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—TYMS—stomach cancer	3.78e-05	0.000222	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—FYN—stomach cancer	3.77e-05	0.000221	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—CAV1—stomach cancer	3.75e-05	0.00022	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—APOA1—stomach cancer	3.75e-05	0.000219	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—GSTM1—stomach cancer	3.74e-05	0.000219	CbGpPWpGaD
Brimonidine—ADRA2A—Hemostasis—MAPK1—stomach cancer	3.69e-05	0.000216	CbGpPWpGaD
Brimonidine—AOX1—Metabolism—PIK3CA—stomach cancer	3.66e-05	0.000215	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—IL6R—stomach cancer	3.65e-05	0.000214	CbGpPWpGaD
Brimonidine—ADRA2C—Hemostasis—HRAS—stomach cancer	3.65e-05	0.000213	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR downstream signaling—RHOA—stomach cancer	3.63e-05	0.000213	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—CXCL8—stomach cancer	3.56e-05	0.000209	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—ADRB2—stomach cancer	3.54e-05	0.000207	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—FGFR2—stomach cancer	3.54e-05	0.000207	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—ERCC2—stomach cancer	3.52e-05	0.000206	CbGpPWpGaD
Brimonidine—ADRA2A—Hemostasis—KRAS—stomach cancer	3.48e-05	0.000204	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—PPP2R1A—stomach cancer	3.47e-05	0.000203	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—IRS2—stomach cancer	3.47e-05	0.000203	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—CAV1—stomach cancer	3.36e-05	0.000197	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—APOA1—stomach cancer	3.35e-05	0.000196	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—MTHFR—stomach cancer	3.31e-05	0.000194	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—PPARG—stomach cancer	3.3e-05	0.000193	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—RHOA—stomach cancer	3.3e-05	0.000193	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—IRS2—stomach cancer	3.24e-05	0.00019	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—SMAD4—stomach cancer	3.22e-05	0.000189	CbGpPWpGaD
Brimonidine—ADRA2A—Hemostasis—PIK3CA—stomach cancer	3.2e-05	0.000187	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—PRKCB—stomach cancer	3.2e-05	0.000187	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR downstream signaling—CXCL8—stomach cancer	3.19e-05	0.000187	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—IL6ST—stomach cancer	3.19e-05	0.000187	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—CAV1—stomach cancer	3.14e-05	0.000184	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—APOA1—stomach cancer	3.13e-05	0.000183	CbGpPWpGaD
Brimonidine—ADRA2A—Hemostasis—TP53—stomach cancer	3.1e-05	0.000181	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—APC—stomach cancer	3.06e-05	0.000179	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—FYN—stomach cancer	3.06e-05	0.000179	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—CAV1—stomach cancer	3.05e-05	0.000179	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—APOA1—stomach cancer	3.04e-05	0.000178	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—PRKCB—stomach cancer	2.99e-05	0.000175	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—IL6ST—stomach cancer	2.98e-05	0.000174	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—ALB—stomach cancer	2.97e-05	0.000174	CbGpPWpGaD
Brimonidine—ADRA2A—Hemostasis—HRAS—stomach cancer	2.96e-05	0.000173	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—MAPK3—stomach cancer	2.93e-05	0.000172	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—CXCL8—stomach cancer	2.9e-05	0.00017	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—FGFR2—stomach cancer	2.87e-05	0.000168	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—APC—stomach cancer	2.86e-05	0.000167	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—IL6R—stomach cancer	2.84e-05	0.000166	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—NOS3—stomach cancer	2.84e-05	0.000166	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—MAPK1—stomach cancer	2.79e-05	0.000163	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—EGFR—stomach cancer	2.79e-05	0.000163	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—MAPK3—stomach cancer	2.74e-05	0.00016	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—PPARG—stomach cancer	2.68e-05	0.000157	CbGpPWpGaD
Brimonidine—ADRA2B—GPCR downstream signaling—PIK3CA—stomach cancer	2.67e-05	0.000156	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—SERPINE1—stomach cancer	2.66e-05	0.000156	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—IL6R—stomach cancer	2.66e-05	0.000156	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—KRAS—stomach cancer	2.63e-05	0.000154	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—IRS2—stomach cancer	2.63e-05	0.000154	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—MAPK1—stomach cancer	2.61e-05	0.000153	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—EGFR—stomach cancer	2.61e-05	0.000153	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—PTGS2—stomach cancer	2.6e-05	0.000152	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—RHOA—stomach cancer	2.57e-05	0.00015	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—CAV1—stomach cancer	2.55e-05	0.000149	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—APOA1—stomach cancer	2.54e-05	0.000149	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—NOS3—stomach cancer	2.54e-05	0.000149	CbGpPWpGaD
Brimonidine—ADRA2C—GPCR downstream signaling—PIK3CA—stomach cancer	2.49e-05	0.000146	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—SERPINE1—stomach cancer	2.49e-05	0.000146	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—KRAS—stomach cancer	2.46e-05	0.000144	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—PRKCB—stomach cancer	2.43e-05	0.000142	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—PIK3CA—stomach cancer	2.42e-05	0.000142	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—IL6ST—stomach cancer	2.42e-05	0.000142	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—ALB—stomach cancer	2.41e-05	0.000141	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—RHOA—stomach cancer	2.4e-05	0.00014	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—ERBB2—stomach cancer	2.38e-05	0.000139	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—NOS3—stomach cancer	2.37e-05	0.000139	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—APC—stomach cancer	2.32e-05	0.000136	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—NOS3—stomach cancer	2.31e-05	0.000135	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—PIK3CA—stomach cancer	2.26e-05	0.000132	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—CXCL8—stomach cancer	2.25e-05	0.000132	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—HRAS—stomach cancer	2.24e-05	0.000131	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—MAPK3—stomach cancer	2.22e-05	0.00013	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—ERBB2—stomach cancer	2.22e-05	0.00013	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—CDKN1B—stomach cancer	2.2e-05	0.000129	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—IL6R—stomach cancer	2.16e-05	0.000126	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—IL6—stomach cancer	2.14e-05	0.000126	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—MAPK1—stomach cancer	2.12e-05	0.000124	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—EGFR—stomach cancer	2.12e-05	0.000124	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—PTGS2—stomach cancer	2.11e-05	0.000124	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—CXCL8—stomach cancer	2.11e-05	0.000123	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—CCND1—stomach cancer	2.1e-05	0.000123	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—JUN—stomach cancer	2.1e-05	0.000123	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—HRAS—stomach cancer	2.09e-05	0.000123	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—CDKN1B—stomach cancer	2.06e-05	0.00012	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—MMP9—stomach cancer	2.04e-05	0.000119	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—CDKN1A—stomach cancer	2.03e-05	0.000119	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR downstream signaling—PIK3CA—stomach cancer	2.02e-05	0.000118	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—SERPINE1—stomach cancer	2.02e-05	0.000118	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—IL6—stomach cancer	2e-05	0.000117	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—KRAS—stomach cancer	2e-05	0.000117	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—MAPK8—stomach cancer	1.98e-05	0.000116	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—CCND1—stomach cancer	1.96e-05	0.000115	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—JUN—stomach cancer	1.96e-05	0.000115	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—RHOA—stomach cancer	1.95e-05	0.000114	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—NOS3—stomach cancer	1.93e-05	0.000113	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—MMP9—stomach cancer	1.9e-05	0.000112	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—CDKN1A—stomach cancer	1.9e-05	0.000111	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—MAPK8—stomach cancer	1.85e-05	0.000108	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—PIK3CA—stomach cancer	1.84e-05	0.000108	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—VEGFA—stomach cancer	1.83e-05	0.000107	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—STAT3—stomach cancer	1.81e-05	0.000106	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—ERBB2—stomach cancer	1.8e-05	0.000106	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—MAPK3—stomach cancer	1.73e-05	0.000101	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—CXCL8—stomach cancer	1.71e-05	0.0001	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—VEGFA—stomach cancer	1.71e-05	0.0001	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—HRAS—stomach cancer	1.7e-05	9.95e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—STAT3—stomach cancer	1.69e-05	9.92e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—MYC—stomach cancer	1.68e-05	9.87e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—CDKN1B—stomach cancer	1.67e-05	9.78e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—MAPK1—stomach cancer	1.65e-05	9.65e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—EGFR—stomach cancer	1.65e-05	9.65e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—IL6—stomach cancer	1.63e-05	9.52e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—MAPK3—stomach cancer	1.62e-05	9.48e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—PIK3CA—stomach cancer	1.6e-05	9.36e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—CCND1—stomach cancer	1.59e-05	9.33e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—JUN—stomach cancer	1.59e-05	9.31e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—MYC—stomach cancer	1.57e-05	9.22e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—KRAS—stomach cancer	1.56e-05	9.12e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—MMP9—stomach cancer	1.55e-05	9.06e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—CDKN1A—stomach cancer	1.54e-05	9.03e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—MAPK1—stomach cancer	1.54e-05	9.02e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—EGFR—stomach cancer	1.54e-05	9.01e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—MAPK8—stomach cancer	1.5e-05	8.81e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—KRAS—stomach cancer	1.45e-05	8.52e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—PIK3CA—stomach cancer	1.43e-05	8.37e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—VEGFA—stomach cancer	1.39e-05	8.14e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—TP53—stomach cancer	1.38e-05	8.1e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—STAT3—stomach cancer	1.38e-05	8.06e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—PIK3CA—stomach cancer	1.34e-05	7.82e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—HRAS—stomach cancer	1.32e-05	7.75e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—MAPK3—stomach cancer	1.31e-05	7.7e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—PIK3CA—stomach cancer	1.3e-05	7.6e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—TP53—stomach cancer	1.29e-05	7.57e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—MYC—stomach cancer	1.28e-05	7.49e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—IL6—stomach cancer	1.27e-05	7.42e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—MAPK1—stomach cancer	1.25e-05	7.32e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—EGFR—stomach cancer	1.25e-05	7.32e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—HRAS—stomach cancer	1.24e-05	7.24e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—IL6—stomach cancer	1.18e-05	6.93e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—KRAS—stomach cancer	1.18e-05	6.92e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—PIK3CA—stomach cancer	1.08e-05	6.35e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—TP53—stomach cancer	1.05e-05	6.15e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—HRAS—stomach cancer	1e-05	5.88e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—IL6—stomach cancer	9.61e-06	5.63e-05	CbGpPWpGaD
